Apart from being used to treat cancer (46), Src inhibitor saracatinib (AZD0530) has been shown to confer ~50% improvement in cardiac conduction velocity and lowered overall arrhythmia episodes by stabilizing membrane Cx43 (43). Here, GJA1 is linked to cancer.